Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

Title

Ellume and Cambridge Consultants Collaborate on Core Technology Behind Ellume’s Rapid Antigen COVID-19 Test

Recent News - Mar. 16, 2021

Congratulations to our colleagues at Cambridge Consultants, who today announced their role in the development of the first fully at-home, prescription-free COVID-19 test to receive U.S. Government Emergency Use Authorization.

The ground-breaking optics technology devised by Cambridge Consultants, coupled with Ellume’s supercharged fluorescent immunochromatography, enabled these sensitive measurements to be performed at home with 96% accuracy.

Learn more about the breakthrough technology on the Cambridge Consultants website.